Coronavirus: EU struggles with shortage of intensive care drugs

The EU is seeking firms to supply 24 intensive care drugs as it struggles to tackle shortages of medicines for COVID-19 patients amid fears of a second wave of infections and strong global demand Reuters reports.

It is the latest move by the executive Commission to coordinate purchases of critical treatments, vaccines and equipment for EU members amid the COVID-19 pandemic.

There are shortages of analgesics, antibiotics, muscle relaxers, anaesthetics and resuscitation drugs, among others, the source said, without identifying the names of the medicines being sought in the tender, because the procedure is not yet concluded.

An internal EU document seen by Reuters shows that in April about 100 medications for COVID-19 patients were in short supply in EU countries.

Among those not available or at risk of shortages in a large number of EU states were analgesic paracetamol; anaesthetics Fentanyl, Midazolam and Propofol; resuscitation drugs Dobutamine and Noradrenaline; muscle relaxers Cisatracurium and Rocuronium; and antibiotics Piperacillin, Azithromycin and Amoxicillin.

These drugs are mostly used in critically ill COVID-19 patients who need to be sedated for intubation.

Steroid Dexamethasone was also seen in April at risk of shortages in Ireland, Cyprus and Luxembourg. The drug, which is made by several generic drugmakers, reduces death rates in hospitalised COVID-19 patients, according to British research.

After the bids, the Commission could strike deals with companies that agree to supply the bloc with their drugs. EU states would then be able to place their orders with the manufacturers.

Joint tenders are meant to avoid competition among EU states for drugs and critical equipment.

Some EU governments have complained EU procedures are too complex, EU officials said. A tender to buy face masks initially received no offers in March. Supplies began flowing later after a second tender.

Most of the 27 EU countries reached a peak in COVID-19 cases, hospitalisations and deaths a few weeks ago, but many have recently seen a resurgence of cases and large localised outbreaks, the bloc’s public health body, the European Centre for Disease Prevention and Control, said last week.

Follow EU Today on Social media:

EUToday Correspondents

EUToday Correspondents

Our team of independent correspondents, based across Europe and beyond, are at the centre of geopolitical dynamics. We are united by our commitment to free and unbiased journalism, and our devotion to the concept of true and unfettered democracy. We take our job very seriously!

Related posts